Live feed06:30:00·1893dPRReleasevia QuantisnowLilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.ByQuantisnow·Wall Street's wire, on your screen.LLY· Eli Lilly and CompanyHealth Care
